Skip to main content
Bruce Stambler, MD, Cardiology, Atlanta, GA, Piedmont Eastside Medical Center

BruceSStamblerMD

Cardiology Atlanta, GA

Adult Congenital Heart Disease, Cardiac Electrophysiology

Professor, Medicine, Case Western Reserve Univ Sch of Med

Dr. Stambler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Stambler's full profile

Already have an account?

Education & Training

  • Beth Israel Deaconess Medical Center/Harvard Medical School
    Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Cardiovascular Disease, 1987 - 1990
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1984 - 1987
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1984

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2014 - 2024
  • OH State Medical License
    OH State Medical License 1998 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Clinical Cardiac Electrophysiology

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Nasal Spray Shows Potential for Quickly Treating ArrhythmiaJuly 2018

Press Mentions

  • Milestone Pharmaceuticals Announces Late-Breaking Presentation of Data from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular Tachycardia at the American Heart Association Scientific Sessions 2022
    Milestone Pharmaceuticals Announces Late-Breaking Presentation of Data from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular Tachycardia at the American Heart Association Scientific Sessions 2022October 25th, 2022
  • Milestone Pharmaceuticals Announces Positive Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular Tachycardia
    Milestone Pharmaceuticals Announces Positive Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular TachycardiaOctober 17th, 2022
  • Milestone Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Corporate Update
    Milestone Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Corporate UpdateAugust 10th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations